Sbarro Health Research Organization founder and Director, Antonio Giordano, M.D., Ph.D., has been recognized with a career award "for the great contributions he has made and which he will continue to make to science, medicine and research." Giordano is director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University as well as a professor of Anatomic Pathology at the University of Siena.
The award was presented to Dr. Giordano on the final day of the second national congress organized by the AIC NET Foundation (Italian Alliance Against Thoraco-Pulmonary Neoplasms) and by the FONICAP Association (Operative National Interdisciplinary Force against Lung Cancer) in Verona, Italy.
In addition to the award, Dr. Giordano has been named chair of the FONICAP Association.
"It is with great pleasure that I accepted this new challenge,” says Giordano, “and I am eager to get work to complete the team of professionals who will join me in this adventure."
Thoraco-pulmonary neoplasms represent a cause of high mortality in Italy and in western countries. Every year, 42,000 new cases occur in Italy and, unfortunately, a still too high percentage of these patients (30-40% and perhaps more) is not correctly treated.
The AIC NET Foundation and the associated scientific assistance platform FONICAP have created a new portal that provides a resource for patients, allowing them to take charge of a multidisciplinary approach to their treatment, exchange experiences, and the possibility of conducting national clinical studies within the FONICAP network.
Moreover, Professor Giordano was recently awarded the prestigious Cristoforo Colombo Prize for 2019 in New York, for the important results obtained in the field of cancer research and for the opportunities for study and work that he was able to create for many young Italian researchers. Presenting the award to Giordano was entrepreneur, philanthropist, and president of Palermo Calcio, Tony Di Piazza, who took part in the ceremony along with representatives from the world of politics, finance, and entertainment.
About the Sbarro Health Research Organization
The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org